| Maximum likelihood estimation for semiparametric regression models with multivariate interval-censored data D Zeng, F Gao, DY Lin Biometrika 104 (3), 505-525, 2017 | 60 | 2017 |
| Semiparametric estimation of the accelerated failure time model with partly interval-censored data F Gao, D Zeng, DY Lin Biometrics 73 (4), 1161-1168, 2017 | 35 | 2017 |
| Semiparametric regression analysis of multiple right-and interval-censored events F Gao, D Zeng, D Couper, DY Lin Journal of the American Statistical Association 114 (527), 1232-1240, 2019 | 23 | 2019 |
| Semiparametric regression analysis of length‐biased interval‐censored data F Gao, KCG Chan Biometrics 75 (1), 121-132, 2019 | 19 | 2019 |
| Sample size calculation for active-arm trial with counterfactual incidence based on recency assay F Gao, DV Glidden, JP Hughes, DJ Donnell Statistical Communications in Infectious Diseases 13 (1), 20200009, 2021 | 13 | 2021 |
| Comparison of condylar position in orthognathic surgery cases treated with virtual surgical planning vs. conventional model planning Y Wan, T Jackson, C Chung, F Gao, G Blakey, T Nguyen Orthodontics & Craniofacial Research 22, 142-148, 2019 | 12 | 2019 |
| Control‐based imputation for sensitivity analyses in informative censoring for recurrent event data F Gao, GF Liu, D Zeng, L Xu, B Lin, G Diao, G Golm, JF Heyse, JG Ibrahim Pharmaceutical statistics 16 (6), 424-432, 2017 | 12 | 2017 |
| Potential use of American College of Radiology BI-RADS mammography atlas for reporting and assessing lesions detected on dedicated breast CT imaging: preliminary study HK Jung, CM Kuzmiak, KW Kim, NM Choi, HJ Kim, EL Langman, S Yoon, ... Academic radiology 24 (11), 1395-1401, 2017 | 10 | 2017 |
| Mathematical modeling of vaccines that prevent SARS-CoV-2 transmission DA Swan, A Goyal, C Bracis, M Moore, E Krantz, E Brown, ... Viruses 13 (10), 1921, 2021 | 9 | 2021 |
| Vaccines that prevent SARS-CoV-2 transmission may prevent or dampen a spring wave of COVID-19 cases and deaths in 2021 DA Swan, A Goyal, C Bracis, M Moore, E Krantz, E Brown, ... medRxiv, 2020.12. 13.20248120, 2020 | 9 | 2020 |
| Microvascular ultrasonic imaging of angiogenesis identifies tumors in a murine spontaneous breast cancer model SE Shelton, J Stone, F Gao, D Zeng, PA Dayton International Journal of Biomedical Imaging 2020, 2020 | 9 | 2020 |
| On inference of control-based imputation for analysis of repeated binary outcomes with missing data F Gao, G Liu, D Zeng, G Diao, JF Heyse, JG Ibrahim Journal of Biopharmaceutical Statistics 27 (3), 358-372, 2017 | 9 | 2017 |
| Counterfactual estimation of CAB-LA efficacy against placebo using external trial data D Donnell, F Gao, J Hughes, B Hanscom, L Corey, M Cohen Conference on Retroviruses and Opportunistic Infections (CROI), 2022 | 7 | 2022 |
| Semiparametric regression analysis of interval-censored data with informative dropout F Gao, D Zeng, DY Lin Biometrics 74 (4), 1213-1222, 2018 | 7 | 2018 |
| Hypothesis testing for two‐stage designs with over or under enrollment D Zeng, F Gao, K Hu, C Jia, JG Ibrahim Statistics in medicine 34 (16), 2417-2426, 2015 | 7 | 2015 |
| Facilitating next‐generation pre‐exposure prophylaxis clinical trials using HIV recent infection assays: a consensus statement from the Forum HIV Prevention Trial Design Project N Parkin, F Gao, E Grebe, A Cutrell, M Das, D Donnell, A Duerr, ... Clinical Pharmacology & Therapeutics 114 (1), 29-40, 2023 | 6 | 2023 |
| Statistical considerations for cross‐sectional HIV incidence estimation based on recency test F Gao, M Bannick Statistics in medicine 41 (8), 1446-1461, 2022 | 6 | 2022 |
| Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women D Donnell, F Gao, JP Hughes, B Hanscom, L Corey, MS Cohen, ... Journal of the International AIDS Society 26 (6), e26118, 2023 | 3 | 2023 |
| Estimating counterfactual placebo HIV incidence in HIV prevention trials without placebo arms based on markers of HIV exposure Y Zhu, F Gao, D Glidden, D Donnell, H Janes medRxiv, 2022.05. 06.22274780, 2022 | 3 | 2022 |
| Estimating counterfactual placebo HIV incidence in HIV prevention trials without placebo arms based on markers of HIV exposure Y Zhu, F Gao, DV Glidden, D Donnell, H Janes Clinical Trials 21 (1), 114-123, 2024 | 2 | 2024 |
